Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

beta-Thalassemia × luspatercept × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Anemia 4 Primary Myelofibrosis 3 Leukemia, Myeloid, Acute 2 beta-Thalassemia 1 Thrombocytosis 1 Higher-risk Myelodysplastic Syndrome 1

Interventions

luspatercept 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Thiotepa 1 Melphalan 1 Cyclophosphamide 1 Busulfan 1 Antilymphocyte Serum 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04064060 2025-11-12

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Celgene

Phase 3 Recruiting

Myelodysplastic Syndromes, Myeloproliferative Disorders, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡